Funding for this research was provided by:
National Natural Science Foundation of China (81273257, 81471584)
Tianjin Application Basis and CuttingEdge Technology Research Grant (14JCZDJC35700)
Li Jieshou Intestinal Barrier Research Special Fund (LJS_201412)
Natural Science Foundation of Tianjin (18JCZDJC35800)
Tianjin Medical University Youth Incubation Fund (No. ZYYFY011)
Received: 3 September 2020
Accepted: 20 October 2020
First Online: 5 November 2020
Ethics approval and consent to participate
: Experiments involving animals were all complied with the standard protocols approved by the Animal Care and Use Committee of Tianjin Medical University (Tianjin, China) (IRB2020-DW-03), according to the Chinese Council on Animal Care guidelines. All human cells’ researches were reviewed and approved by the Medical Ethics Committee of Tianjin Medical University General Hospital (ZYY-IRB-SOP-016(F)-002-04), and the informed consent for experiments using extracted ERCs was obtained from all the participants.
: Not applicable.
: The authors declare that they have no competing interests.